18F-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal Mesothelioma

被引:23
作者
Cao, Qi [1 ]
Lu, Minh [1 ]
Heath, Jonathon [2 ]
Hausner, Petr F. [3 ]
Alexander, H. Richard [4 ]
Dilsizian, Vasken [1 ]
Chen, Wengen [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Surg Oncol, Baltimore, MD 21201 USA
关键词
peritoneal mesothelioma; FDG PET/CT; ASBESTOS;
D O I
10.1097/RLU.0b013e3182478bb5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Peritoneal mesothelioma is a rare and aggressive tumor. Early diagnosis of the disease is difficult, delaying effective treatment. We report a case of recurrent, biphasic, diffuse, malignant peritoneal mesothelioma. Initial abdominal computed tomography showed abnormal but nonspecific findings suggestive of an ovarian malignancy, with a negative endoscopy and laboratory studies. An abdominal exploratory laparotomy found widespread malignancy within the peritoneum with a pathological diagnosis of peritoneal mesothelioma. A PET/CT imaging showed diffusely increased metabolic activity throughout the peritoneum, with no evidence of thoracic or pleural involvement. This case demonstrates the PET/CT findings seen with malignant recurrent peritoneal mesothelioma. © 2012 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:492 / 494
页数:3
相关论文
共 10 条
[1]   Malignant mesothelioma of the peritoneum as the cause of a paraneoplastic syndrome:: detection by 18F-FDG PET [J].
Banayan, Soraya ;
Hot, Arnaud ;
Janier, Marc ;
Ninet, Jacques ;
Zurlinden, Olivier ;
Billotey, Claire .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (06) :751-751
[2]   The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma [J].
Davidson, Ben ;
Risberg, Bjorn ;
Berner, Aasmund ;
Bedrossian, Carlos W. M. ;
Reich, Reuven .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2006, 23 (01) :35-43
[3]   Primary malignant peritoneal mesothelioma - Appearance on F-18FDG positron emission tomographic images [J].
Eade, TN ;
Fulham, MJ ;
Constable, CJ .
CLINICAL NUCLEAR MEDICINE, 2002, 27 (12) :924-925
[4]   Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy [J].
Feldman, AL ;
Libutti, SK ;
Pingpank, JF ;
Bartlett, DL ;
Beresnev, TH ;
Mavroukakis, SM ;
Steinberg, SM ;
Liewehr, DJ ;
Kleiner, DE ;
Alexander, HR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4560-4567
[5]   Asbestos-induced lung diseases: an update [J].
Kamp, David W. .
TRANSLATIONAL RESEARCH, 2009, 153 (04) :143-152
[6]  
Manzini VD, 2005, TUMORI J, V91, P1
[7]  
Noguchi Tadaaki, 2010, Gan To Kagaku Ryoho, V37, P1975
[8]  
Lorenzo JP, 2007, AN MED INTERN, V24, P81
[9]   Malignant mesothelioma [J].
Rudd, R. M. .
BRITISH MEDICAL BULLETIN, 2010, 93 (01) :105-123
[10]   Results of treatment of 33 patients with peritoneal mesothelioma [J].
Sebbag, G ;
Yan, H ;
Shmookler, BM ;
Chang, D ;
Sugarbaker, PH .
BRITISH JOURNAL OF SURGERY, 2000, 87 (11) :1587-1593